Sonoma Pharmaceuticals Inc Working Capital to Net Assets Ratio
Sonoma Pharmaceuticals Inc working capital to net assets ratio. Sonoma Pharmaceuticals Inc (SNOA) has a Working Capital to Net Assets ratio of 164.1% as of June 2026. Working capital of $10.82 Million (current assets of $16.27 Million minus current liabilities of $5.45 Million) is measured against net assets of $6.59 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Sonoma Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sonoma Pharmaceuticals Inc (2005–2026)
Working capital to net assets ratio of Sonoma Pharmaceuticals Inc from 2005 to 2026. This chart shows how Sonoma Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2005 to 2026. As of June 2026, the ratio stands at 164.1%, reflecting working capital of $10.82 Million against net assets of $6.59 Million USD. See Sonoma Pharmaceuticals Inc (SNOA) liquidity interval to measure how many days the company can operate on defensive assets alone.
Sonoma Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2005–2026)
Sonoma Pharmaceuticals Inc working capital to net assets ratio by year from 2005 to 2026. The table below presents the year-by-year Working Capital to Net Assets ratio for Sonoma Pharmaceuticals Inc from 2005 to 2026, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SNOA total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 234.8% | $7.27 Million | $3.10 Million | $12.10 Million | $4.83 Million | ▲ +41.0 pp |
| 2025 | 193.9% | $8.55 Million | $4.41 Million | $12.65 Million | $4.10 Million | ▲ +50.0 pp |
| 2024 | 143.9% | $8.83 Million | $6.14 Million | $12.55 Million | $3.72 Million | ▲ +17.5 pp |
| 2023 | 126.4% | $10.08 Million | $7.98 Million | $13.80 Million | $3.72 Million | ▲ +4.4 pp |
| 2022 | 122.0% | $10.61 Million | $8.70 Million | $16.43 Million | $5.82 Million | ▼ -40.1 pp |
| 2021 | 162.1% | $8.70 Million | $5.36 Million | $12.77 Million | $4.08 Million | ▲ +26.1 pp |
| 2020 | 136.1% | $7.65 Million | $5.62 Million | $12.38 Million | $4.73 Million | ▲ +51.2 pp |
| 2019 | 84.9% | $8.90 Million | $10.49 Million | $12.50 Million | $3.59 Million | ▲ +0.1 pp |
| 2018 | 84.8% | $12.99 Million | $15.33 Million | $16.25 Million | $3.26 Million | ▼ -5.5 pp |
| 2017 | 90.3% | $19.36 Million | $21.43 Million | $22.64 Million | $3.29 Million | ▼ -1.8 pp |
| 2016 | 92.1% | $9.34 Million | $10.14 Million | $12.89 Million | $3.55 Million | ▲ +33.5 pp |
| 2015 | 58.6% | $7.07 Million | $12.05 Million | $9.65 Million | $2.58 Million | ▲ +42.3 pp |
| 2014 | 16.3% | $1.97 Million | $12.06 Million | $9.54 Million | $7.57 Million | ▼ -140.7 pp |
| 2013 | 157.0% | $6.41 Million | $4.08 Million | $11.53 Million | $5.13 Million | ▲ +411.7 pp |
| 2012 | -254.7% | $2.21 Million | $-868.00K | $6.96 Million | $4.75 Million | ▼ -454.3 pp |
| 2011 | 199.5% | $3.39 Million | $1.70 Million | $7.81 Million | $4.42 Million | ▲ +109.9 pp |
| 2010 | 89.6% | $6.32 Million | $7.04 Million | $9.05 Million | $2.73 Million | ▲ +34.0 pp |
| 2009 | 55.7% | $1.26 Million | $2.27 Million | $3.94 Million | $2.68 Million | ▼ -31.8 pp |
| 2008 | 87.5% | $13.50 Million | $15.43 Million | $20.95 Million | $7.45 Million | ▼ -5.3 pp |
| 2007 | 92.8% | $13.83 Million | $14.90 Million | $23.87 Million | $10.03 Million | ▲ +23.0 pp |
| 2006 | 69.9% | $5.13 Million | $7.34 Million | $10.23 Million | $5.10 Million | ▲ +39.8 pp |
| 2005 | 30.1% | $663.00K | $2.20 Million | $4.88 Million | $4.22 Million | — |